期刊文献+

病灶糖酵解总量变化对兔VX2肿瘤放疗反应的早期预测价值 被引量:2

Value of total lesion glycolysis change for early assessment of radiotherapy response in VX2 tumor bearing rabbit models
原文传递
导出
摘要 目的 探讨18 F-FDG PET/CT代谢参数对兔VX2肿瘤放疗敏感性的早期预测价值.方法 采用瘤块皮下种植法建立兔VX2肿瘤模型,将28只新西兰大白兔采用随机数字表法分为放疗组(n=21)和对照组(n=7),放疗组给予单次剂量为20 Gy的放疗,并分别于治疗前1d及治疗后第7天行18F-FDG PET/CT检查;对照组于相同时间点进行相应检查.具体观测参数包括SUVmax、MTV和TLG.计算各参数的变化率(△SUV、△MTV和△TLG).显像结束后取肿瘤组织行组织病理学分析,计算肿瘤细胞坏死率、炎性细胞浸润率及细胞增殖核抗原Ki67阳性率.按放疗后第7天的肿瘤体积变化状况,将放疗组分为放疗抵抗组和放疗有效组,组间比较采用Mann-Whitneyu检验;组织病理学参数与△TLG间的相关性采用Pearson相关分析.结果 放疗后第7天,放疗抵抗组(n=12)与有效组(n=7)比较,△MTV差异无统计学意义[(51.0±52.0)%和(23.0±47.0)%;u=44.0,P>0.05];而△SUV[(10.0±32.0)%和(-36.0±22.0)%]、△TLG[(76.0±90.0)%和(-15.0±44.0)%]存在差异(u=75.0和71.0,均P<0.05).病理分析发现放疗有效组肿瘤组织存在大量坏死灶及炎性细胞,有效组坏死率明显高于抵抗组[(63.0±15.0)%和(36.0±5.0)%;u=7.5,P<0.05],有效组炎性细胞浸润率也高于抵抗组[(61.0±13.0)%和(43.0±15.0)%;u=18.5,P<0.05].免疫组织化学分析发现,放疗有效组细胞增殖核抗原Ki67阳性率明显低于放疗抵抗组[(79.0±19.0)%和(130.0±45.0)%;u=81.5,P<0.05].△TLG与肿瘤组织坏死率呈负相关(r=-0.57,P<0.05).结论 △TLG有望作为VX2肿瘤放疗效果的早期评估指标,用于指导肿瘤治疗方案的调整并在随访中发挥作用. Objective To evaluate the predictive value of TLG in 18F-FDG PET/CT for early response to radiotherapy in VX2 tumor bearing rabbit models.Methods The rabbit models were established by transplanting VX2 tumor tissue into muscles of right legs.A total of 28 New Zealand rabbits were divided into control group (n =7) and radiation group (n =21) using random number table.1 8F-FDG PET studies were performed 1 d before and 7 d after radiotherapy (20 Gy),and tumor glucose metabolic parameters (SUV,MTV,TLG,△SUV,△MTV,△TLG) were calculated.Based on histopathological analysis of the tumor specimens obtained after PET scan,the ratios of tumor cell necrosis,inflammatory cells infiltration and Ki67 positive staining were calculated.If a tumor doubled in volume or more than that on day 7,it was included into resistance group.Others were included into response group.The prognostic significance of △SUV,△MTV,△TLG was assessed by Mann-Whitney u test,the correlation between histopathological necrosis ratio and the change of TLG was analyzed by Pearson correlation analysis.Results Seven days after radiotherapy,there was no difference in △MTV value between the response group (n =7) and the resistance group (n=12):(23.0±47.0)% vs (51.0±52.0)%; u=44.0,P〉0.05.However,there were significant differences in △SUV ((-36.0±22.0)% vs (10.0±32.0)%; u=75.0) and △TLG ((-15.0±44.0) % vs (76.0±90.0)%,u =71.0) values between the 2 groups (both P〈0.05).Histopathological analysis confirmed that there were a large number of necrotic foci and inflammatory cells in the response group.Significant differences in necrosis rate and inflammatory cells infiltration were found between the response group and resistance group ((63.0±15.0)% vs (36.0±5.0)%,u=7.5; (61.0±13.0)% vs (43.0±15.0)%,u=18.5;both P〈0.05),and the Ki67-positive rate significantly reduced ((79.0± 19.0)% vs (130.0±45.0)%,u=81.5,P〈0.05).△TLG and tumor necrosis rate were correlated significantly (r=-0.57,P〈0.05).Conclusion △TLG may have potential to predict early response to radiotherapy in VX2 tumor,and it could be helpful in tumor therapeutic planning and follow-up.
出处 《中华核医学与分子影像杂志》 北大核心 2015年第1期48-52,共5页 Chinese Journal of Nuclear Medicine and Molecular Imaging
基金 新一轮上海市卫生系统学科带头人培养计划(XBR2011040) 上海领军人才队伍建设专项资金(2011-056) 上海市博士后科研资助计划(11R21410600) 第二军医大学长海医院“1255”学科建设资助项目(CHl25521103)
关键词 肿瘤 病灶糖酵解总量 放射疗法 体层摄影术 发射型计算机 体层摄影术 X线计算机 脱氧葡萄糖 Neoplasms Total lesion glycolysis Radiotherapy Tomography,emission-computed Tomography,X-ray computed Deoxyglucose Rabbits
  • 相关文献

参考文献22

  • 1Baskar R, Lee KA, Yeo R, et al. Cancer and radiation therapy: current advances and future directions[J]. IntJ Med Sci, 2012, 9 (3): 193-199.
  • 2Grunnet M, SorensenJB. Carcinoembryonic antigen (CEA) as tumor marker in lung cancer[J]. Lung Cancer, 2012, 76 ( 2) : 138-143.
  • 3Eisenhauer EA, Therasse P, BogaertsJ, et al. New response eval?uation criteria in solid tumours: revised RECIST guideline (version 1.1)[J]. EurJ Cancer, 2009, 45 (2) : 228-247.
  • 4Wahl RL,Jacene H, Kasamon Y, et al. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors[J].J Nucl Med, 2009, 50 Suppl 1: 122S-150S.
  • 5Song SL, LiuJ J, Huang G, et al. Changes in 18F_FOG uptake within minutes after chemotherapy in a rabbit VX2 tumor model[J].J Nucl Med, 2008, 49(2): 303-309.
  • 6Ciernik IF, Dizendorf E, Baumert BG, et al. Radiation treatment planning with an integrated positron emission and computer tomo?graphy (PET/CT) : a feasibility study[J]. IntJ Radiat Oncol Bioi Phys, 2003, 57 (3) : 853-863.
  • 7Yamamoto Y, Nishiyama Y, Ishikawa S, et al. Correlation of 18 F - FLT and 18F_FOG uptake on PET with Ki-67 immunohistochemistry in non-small cell lung cancer[J]. EurJ Nucl Med Mol Imaging, 2007, 34( 10) : 1610-1616.
  • 8Liapi E, GeschwindJF, Vali M, et al. Assessment of tumoricidal efficacy and response to treatment with 18F -FOG PET/CT after in?traarterial infusion with the antiglycolytic agent 3-bromopyruvate in the VX2 model of liver tumor[J]. J Nucl Med, 2011, 52(2) : 225 -230.
  • 9Ishii K, Hosono MN, Wada Y, et al. Usefulness of FOG-microPET for early evaluation of therapeutic effects on VX2 rabbit carcinoma[J]. Ann Nucl Med, 2006, 20(2): 123-130.
  • 10Castaldi P, Rufini V, Bussu F, et al. Can "early" and "late" 18 F?FOG PET/CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy[J]? Radiother Oncol, 2012, 103 ( 1) : 63-68.

二级参考文献21

  • 1李家敏,孙启银,杨乃明,王明芳,黄术林,张登胜,赵军,孙爱君,李娜,黄少勇.^(18)F-FDG PET显像鉴别肺部单发肿块性质及肺癌分期的价值[J].中华核医学杂志,1997,17(2):77-79. 被引量:27
  • 2Baum RP, Hellwig D, Mezzetti M. Position of nuclear medicine modalities in the diagnostic workup of cancer patients: lung cancer[J]. Q.J Nncl Med Mol Imaging, 2004, 48(2): 119-142.
  • 3Ciernik IF, Dizendorf E, Baumert BG, et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study[J]. Int J Radiat Oncol Biol Phys, 2003, 57(3): 853-863.
  • 4Leong T, Everitt C, Yuen K, et al. A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer[J]. Radiother Oncol, 2006, 78(3): 254-261.
  • 5Hong R, Halama J, Bova D, et al. Correlation of PET standard uptake value and CT window-level thresholds for target delineation in CT-based radiation treatment planning[J]. Int J Radiat Oncol Biol Phys, 2007, 67(3): 720-726.
  • 6Bayne M, Macmanus M, Hicks R, et al. Can a mathematical formula help define a radiation target volume using positron emission tomography? In regard to Black et al. (Int J Radiat Oncol Biol Phys, 2004, 60: 1272-1282)[J]. Int J Radiat Oncol Biol Plays, 2005, 62(1): 299-300.
  • 7Daisne JF, Sibomana Mj Bol A, et al. Tri-dimensional automatic segmentation of PET volumes based on measured source-to- background ratios: influence of reconstruction algorithms[J]. Radiother Oncol, 2003, 69 (3): 247-250.
  • 8Kao CH, Hsieh TC, Yu CY, et al. ^18F-FDG PET/CT-based gross tumor volume definition for radiotherapy in head and neck cancer: a correlation study between suitable uptake value threshold and tumor parameters[J]. Radiat Oncol, 2010, 5: 76.
  • 9Yu J, Li X, Xing L, et al. Comparison of tumor volumes as determined by pathologic examination and FDG-PET/CT images of non-small-cell lung cancer: a pilot study[J]. Int J Radiat Oncol Biol Phys, 2009, 75(5): 1468-1474.
  • 10Malyapa RS, Mutic S, Low DA, et al. Physiologic FDG-PET three-dimensional brachytherapy treatment planning for cervical cancer[J]. Int J Radiat Oncol Biol Phys, 2002, 54(4): 1140- 1146.

共引文献67

同被引文献8

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部